Prochlorperazine Edisylate NDC 55154-4183

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-4183Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-4183Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-4183-5	55154418305	5 VIAL in 1 BAG (55154-4183-5) / 2 mL in 1 VIALMarketed from Mar 26, 2012

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prochlorperazine Edisylate
Generic name (nonproprietary): prochlorperazine edisylate
Active ingredients: Prochlorperazine edisylate — 5 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Cardinal Health 107, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204147
Marketing start: Mar 26, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 55154-4183_5ad400a8-04d3-42e7-84b7-b5da30dcb859SPL ID 5ad400a8-04d3-42e7-84b7-b5da30dcb859SPL set ID 6135944c-3ee2-4491-9704-33f56ad435f4RxCUI 314192UNII PG20W5VQZS
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455154418305 followed by a unit qualifier and the quantity

Package 55154-4183-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE To control severe nausea and vomiting. For the treatment of schizophrenia. Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204147

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204147
Product	Strength	Form · route	Labeler	Product NDC
Prochlorperazine Edisylate	Prochlorperazine edisylate 5 mg/mL	InjectionIntramuscular, Intravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-294
Prochlorperazine Edisylate	Prochlorperazine edisylate 5 mg/mL	InjectionIntramuscular, Intravenous	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-523
prochlorperazine edisylate	Prochlorperazine edisylate 5 mg/mL	Injection, SolutionIntramuscular, Intravenous	Avenacy Inc.	83634-778